Gadoterate Meglumine
Active substance: gadoterate meglumine
INJECTION · GADOTERATE MEGLUMINE 376.9 mg/mL
United StatesActive
Marketing holder: Fresenius Kabi USA, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- GADOTERATE MEGLUMINE · 376.9 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12090-c1ed-789e-a9fb-91d1f1207b6f,01a12092-51b1-741d-a1e8-047dc10bfec3,01a12094-38b1-7339-be5b-f95da642afb2,01a12094-38cd-79d7-97e4-96493cc9adde,01a12096-ef85-70dd-87c9-c69088e021b0;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 65219-086
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 65219-086 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 65219-086 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 65219-086 · Verified 2026-10-09 · open in source